AN2 Therapeutics (ANTX)
(Delayed Data from NSDQ)
$2.55 USD
-0.01 (-0.39%)
Updated Jul 31, 2024 04:00 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.63 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | 8.20% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.44 |
Next Year | -2.38 |
EPS (TTM) | -2.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.63 | -0.66 | -2.44 | -2.38 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | -1.75 |
High Estimate | -0.60 | -0.60 | -2.25 | -1.75 |
Low Estimate | -0.65 | -0.71 | -2.69 | -2.72 |
Year ago EPS | -0.81 | -0.65 | -2.74 | -2.44 |
Year over Year Growth Est. | 22.22% | -1.54% | 10.95% | 2.19% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.63 | -0.66 | -2.44 | -2.38 |
7 Days Ago | -0.63 | -0.66 | -2.44 | -2.38 |
30 Days Ago | -0.63 | -0.66 | -2.44 | -2.37 |
60 Days Ago | -0.63 | -0.66 | -2.44 | -2.37 |
90 Days Ago | -0.66 | -0.69 | -2.54 | -2.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.63 | -0.66 | -2.44 | -1.75 |
Zacks Consensus Estimate | -0.63 | -0.66 | -2.44 | -2.38 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 26.57% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.57 | -0.65 | -0.81 | NA |
Estimate | -0.61 | -0.71 | -0.63 | -0.85 | NA |
Difference | 0.05 | 0.14 | -0.02 | 0.04 | 0.05 |
Surprise | 8.20% | 19.72% | -3.17% | 4.71% | 7.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more